Motion Sickness Drugs Market by Product, Distribution Channel, and Geography - Forecast and Geography 2023-2027

Published: May 2023

Pages: 160

SKU: IRTNTR74414

Snapshot

Motion Sickness Drugs Market Analysis Report 2023-2027:

The motion sickness drugs market size is estimated to grow at a CAGR of 4.43% between 2022 and 2027. The market size is forecast to increase by USD 136.49 million. The growth of the market depends on several factors, including the availability of over-the-counter (OTC) drugs, the availability of motion sickness drugs in multiple dosage forms, and growing travel and tourism worldwide.

This motion sickness drugs market report extensively covers market segmentation by product (antihistamines and anticholinergics), distribution channel (offline and online), and geography North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the Size of the Motion Sickness Drugs Market During the Forecast Period?

To learn more about this report, View Report Sample

Motion Sickness Drugs Market: Key Drivers, Trends, Challenges, and Customer Landscape

The availability of over-the-counter (OTC) drugs is notably driving the market growth, although factors such as the launch of generics may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Motion Sickness Drugs Market Driver

The availability of over-the-counter (OTC) drugs is notably driving the market growth. The global motion sickness drug market is largely served by generic drugs, available both by prescription and over-the-counter. Anticholinergics and antihistamines are considered first-line treatments for controlling and preventing symptoms associated with motion sickness. Several antihistamines are available over the counter and can be used by pediatric patients. These drugs are used primarily to prevent symptoms of motion sickness, not as a treatment. OTC medicines are medicines sold directly to patients or consumers without a doctor's prescription. The availability of these OTC medicines increases their availability and affordability, allowing patients the freedom to self-medicate symptoms associated with mild illness. In addition, the availability of OTC medicines reduces the financial burden associated with drug treatment, as prescriptions are no longer required to purchase these medicines.

Antihistamines are commonly used to prevent and treat motion sickness. First-generation antihistamines include diphenhydramine, dimenhydrinate, meclizine, chlorpheniramine, and promethazine. Second-generation antihistamines include cetirizine and fexofenadine. However, they are not as effective as first-generation antihistamines because they have insufficient central cholinergic activity. The over-the-counter availability of antihistamines has increased the acceptance of antihistamines among patients suffering from motion sickness, thereby driving the growth of the market.

Significant Motion Sickness Drugs Market Trends

The increased penetration of online channels is the major trend shaping the market. Online drug sales have become increasingly popular in recent years due to their convenience. The COVID-19 pandemic has increased the demand for medicines such as motion sickness medicine through online channels. The rise of telemedicine and virtual consultations has made it easier for patients to receive prescriptions online.

Online platforms offer an easy and convenient way for consumers to purchase medicines from the comfort of their own homes. With the prevalence of technology and the internet, more and more people are adopting e-commerce platforms for pharmaceuticals such as motion sickness remedies, which is expected to drive the growth of the global motion sickness remedies market during the forecast period.

Major Motion Sickness Drugs Challenge

The launch of generics may impede the growth of the market. The introduction of generic drugs in recent years has adversely affected the growth of the global motion sickness drug market. After the introduction of generic drugs, the branded version will be marketed. Generic drugs are cheaper drugs that contain the same active ingredients as the original drug. These drugs enter the market shortly after branded drugs lose their patent exclusivity.

After patent exclusivity is lost, generic product competition increases, leading to lower sales of branded drugs as generic competitors enter the market at lower prices for the same products. This also increases the threat of new market entrants, which in turn impacts the market position of incumbent players. Once these generic drugs are introduced in developed countries, they reach developing countries in a short period of time. Such incidents are estimated to adversely affect the markets of developing countries during the forecast period.

Key Motion Sickness Drugs Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Motion Sickness Drugs Market Customer Landscape

Who are the Major Motion Sickness Drugs Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbott Laboratories: The company offers motion sickness drug called Avomine tablet composed of Promethazine.

The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Motion Sickness Drugs Market?

The market share growth by the antihistamines segment will be significant during the forecast period. This segment includes cinnarizine, promethazine hydrochloride, promethazine thecate, and meclizine. First-generation antihistamines have antiallergic, antitussive, antipruritic, and antiemetic effects. The antiemetic effect was attributed to the blockade of histamine 1 receptors (H1) and muscarinic receptors. All four drugs have similar pharmacological activity. However, there are no comparative studies.

Get a glance at the market contribution of various segments View the PDF Sample

The antihistamines segment was valued at USD 275.69 million in 2017 and continued to grow until 2021. The over-the-counter availability of antihistamines has improved the availability and affordability of antihistamines for the general public. Various antihistamines are available to prevent and treat motion sickness. In particular, antihistamines with central cholinergic inhibitory properties have been shown to be effective in preventing or treating motion sickness. This fact suggests that the action of antihistamines on motion sickness is not due to histamine-blocking effects but due to peripheral and central anticholinergic effects. First-generation antihistamines act both centrally and peripherally. Thus, they are widely used by patients suffering from motion sickness, which is driving the growth of the segment.

Which are the Key Regions for the Motion Sickness Drugs Market?

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. This high proportion is due to the existence of large pharmaceutical companies offering both branded and generic motion sickness medications and the existence of an adequate regulatory framework for new drug approval in the region. Additionally, tourism and adventure sports that can cause motion sickness are on the rise in the region, increasing the demand for motion sickness remedies.

The rising disposable income of people has led more and more patients to opt for treatment, contributing to the growth of the North American market. Moreover, increasing focus on investment in R&D activities by major vendors to maintain their market position is expected to have a positive impact on the market in the coming years. Pfizer and Mylan are among the leading players in the region.

This report forecasts the contribution of all the segments to the growth of the market. In addition, we have included the COVID-19 impact and the recovery strategies for each segment. The outbreak of COVID-19 had negatively impacted the growth of the regional market in 2020 and 2021. Lockdowns imposed by governments in the United States, Canada, Mexico, and other countries in 2020 and early 2021 disrupted the supply chain of the motion sickness medicine market in the region, impacting the production and distribution of motion sickness medicines. Customers had limited purchasing power, which negatively impacted market growth. However, in 2021, with the start of a vaccination campaign, the lockdown was lifted and operations resumed. Such factors led to moderate growth in the motion sickness remedy market in North America.

Segment Overview

The motion sickness drugs market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.

Product Outlook (USD Million, 2017 - 2027)
- Antihistamines
- Anticholinergics
Distribution Channel (USD Million, 2017 - 2027)
- Offline
- Online
Region Outlook (USD Million, 2017 - 2027)
- North America
  - The U.S.
  - Canada
- Europe
  - The U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- Rest of World
  - Australia
  - Argentina
  - Rest of the world

Parent Market Analysis

Technavio categorizes the global motion sickness drugs market as a part of the global pharmaceuticals market within the overall healthcare industry. The parent pharmaceuticals market covers products and companies engaged in the R and D or production of generic drugs, non-generic drugs, and veterinary drugs. Our market research report has extensively covered external factors influencing the parent market growth during the forecast period.

Motion Sickness Drugs Market Scope
Report Coverage	Details
Page number	160
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 4.43%
Market growth 2023-2027	USD 136.49 million
Market structure	Fragmented
YoY growth 2022-2023(%)	3.83
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 41%
Key countries	US, Canada, UK, Germany, and China
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	Abbott Laboratories, Amneal Pharmaceuticals Inc., Baxter International Inc., CVS Health Corp., DM Pharma Marketing Pvt. Ltd., GlaxoSmithKline Plc, Hylands, Lupin Ltd., Merck KGaA, Myungmoon Pharm Co. Ltd., Novartis AG, Perrigo Co. Plc, Prestige Consumer Healthcare Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Tivic Health Systems Inc., Viatris Inc., WellSpring Pharmaceutical Corp., Zenomed Healthcare Pvt. Ltd., and Zydus Lifesciences Ltd.
Market dynamics	Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Motion Sickness Drugs Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the market between 2023 and 2027
Precise estimation of the size of the market and its contribution to the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
Thorough analysis of the market’s competitive landscape and detailed information about vendors
Comprehensive analysis of factors that will challenge the growth of market vendors

We can help! Our analysts can customize this market research report to meet your requirements.

Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2022

3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global motion sickness drugs market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on global motion sickness drugs market 2017 - 2021 ($ million)

4.2 Product Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)

4.3 Distribution Channel Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 - 2021 ($ million)

4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

6.1 Market segments
- Exhibit 30: Chart on Product - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Product - Market share 2022-2027 (%)

6.2 Comparison by Product
- Exhibit 32: Chart on Comparison by Product
- Exhibit 33: Data Table on Comparison by Product

6.3 Antihistamines - Market size and forecast 2022-2027
- Exhibit 34: Chart on Antihistamines - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Antihistamines - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Antihistamines - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Antihistamines - Year-over-year growth 2022-2027 (%)

6.4 Anticholinergics - Market size and forecast 2022-2027
- Exhibit 38: Chart on Anticholinergics - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Anticholinergics - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Anticholinergics - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Anticholinergics - Year-over-year growth 2022-2027 (%)

6.5 Market opportunity by Product
- Exhibit 42: Market opportunity by Product ($ million)
- Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
- Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
- Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)

7.2 Comparison by Distribution Channel
- Exhibit 46: Chart on Comparison by Distribution Channel
- Exhibit 47: Data Table on Comparison by Distribution Channel

7.3 Offline - Market size and forecast 2022-2027
- Exhibit 48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
- Exhibit 49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
- Exhibit 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
- Exhibit 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)

7.4 Online - Market size and forecast 2022-2027
- Exhibit 52: Chart on Online - Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
- Exhibit 54: Chart on Online - Year-over-year growth 2022-2027 (%)
- Exhibit 55: Data Table on Online - Year-over-year growth 2022-2027 (%)

7.5 Market opportunity by Distribution Channel
- Exhibit 56: Market opportunity by Distribution Channel ($ million)
- Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 59: Chart on Market share by geography 2022-2027 (%)
- Exhibit 60: Data Table on Market share by geography 2022-2027 (%)

9.2 Geographic comparison
- Exhibit 61: Chart on Geographic comparison
- Exhibit 62: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2022-2027
- Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)

9.4 Europe - Market size and forecast 2022-2027
- Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)

9.5 Asia - Market size and forecast 2022-2027
- Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)

9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

9.7 US - Market size and forecast 2022-2027
- Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)

9.8 Canada - Market size and forecast 2022-2027
- Exhibit 83: Chart on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on Canada - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on Canada - Year-over-year growth 2022-2027 (%)

9.9 UK - Market size and forecast 2022-2027
- Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)

9.10 China - Market size and forecast 2022-2027
- Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)

9.11 Germany - Market size and forecast 2022-2027
- Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)

9.12 Market opportunity by geography
- Exhibit 99: Market opportunity by geography ($ million)
- Exhibit 100: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 101: Impact of drivers and challenges in 2022 and 2027

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 102: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 103: Overview on factors of disruption

11.4 Industry risks
- Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 105: Vendors covered

12.2 Market positioning of vendors
- Exhibit 106: Matrix on vendor position and classification

12.3 Abbott Laboratories
- Exhibit 107: Abbott Laboratories - Overview
- Exhibit 108: Abbott Laboratories - Business segments
- Exhibit 109: Abbott Laboratories - Key news
- Exhibit 110: Abbott Laboratories - Key offerings
- Exhibit 111: Abbott Laboratories - Segment focus

12.4 Amneal Pharmaceuticals Inc.
- Exhibit 112: Amneal Pharmaceuticals Inc. - Overview
- Exhibit 113: Amneal Pharmaceuticals Inc. - Business segments
- Exhibit 114: Amneal Pharmaceuticals Inc. - Key news
- Exhibit 115: Amneal Pharmaceuticals Inc. - Key offerings
- Exhibit 116: Amneal Pharmaceuticals Inc. - Segment focus

12.5 Baxter International Inc.
- Exhibit 117: Baxter International Inc. - Overview
- Exhibit 118: Baxter International Inc. - Business segments
- Exhibit 119: Baxter International Inc. - Key news
- Exhibit 120: Baxter International Inc. - Key offerings
- Exhibit 121: Baxter International Inc. - Segment focus

12.6 CVS Health Corp.
- Exhibit 122: CVS Health Corp. - Overview
- Exhibit 123: CVS Health Corp. - Business segments
- Exhibit 124: CVS Health Corp. - Key news
- Exhibit 125: CVS Health Corp. - Key offerings
- Exhibit 126: CVS Health Corp. - Segment focus

12.7 GlaxoSmithKline Plc
- Exhibit 127: GlaxoSmithKline Plc - Overview
- Exhibit 128: GlaxoSmithKline Plc - Business segments
- Exhibit 129: GlaxoSmithKline Plc - Key news
- Exhibit 130: GlaxoSmithKline Plc - Key offerings
- Exhibit 131: GlaxoSmithKline Plc - Segment focus

12.8 Lupin Ltd.
- Exhibit 132: Lupin Ltd. - Overview
- Exhibit 133: Lupin Ltd. - Product / Service
- Exhibit 134: Lupin Ltd. - Key news
- Exhibit 135: Lupin Ltd. - Key offerings

12.9 Myungmoon Pharm Co. Ltd.
- Exhibit 136: Myungmoon Pharm Co. Ltd. - Overview
- Exhibit 137: Myungmoon Pharm Co. Ltd. - Product / Service
- Exhibit 138: Myungmoon Pharm Co. Ltd. - Key offerings

12.10 Novartis AG
- Exhibit 139: Novartis AG - Overview
- Exhibit 140: Novartis AG - Business segments
- Exhibit 141: Novartis AG - Key offerings
- Exhibit 142: Novartis AG - Segment focus

12.11 Perrigo Co. Plc
- Exhibit 143: Perrigo Co. Plc - Overview
- Exhibit 144: Perrigo Co. Plc - Business segments
- Exhibit 145: Perrigo Co. Plc - Key news
- Exhibit 146: Perrigo Co. Plc - Key offerings
- Exhibit 147: Perrigo Co. Plc - Segment focus

12.12 Prestige Consumer Healthcare Inc.
- Exhibit 148: Prestige Consumer Healthcare Inc. - Overview
- Exhibit 149: Prestige Consumer Healthcare Inc. - Business segments
- Exhibit 150: Prestige Consumer Healthcare Inc. - Key offerings
- Exhibit 151: Prestige Consumer Healthcare Inc. - Segment focus

12.13 Sun Pharmaceutical Industries Ltd.
- Exhibit 152: Sun Pharmaceutical Industries Ltd. - Overview
- Exhibit 153: Sun Pharmaceutical Industries Ltd. - Product / Service
- Exhibit 154: Sun Pharmaceutical Industries Ltd. - Key offerings

12.14 Tivic Health Systems Inc.
- Exhibit 155: Tivic Health Systems Inc. - Overview
- Exhibit 156: Tivic Health Systems Inc. - Product / Service
- Exhibit 157: Tivic Health Systems Inc. - Key offerings

12.15 Viatris Inc.
- Exhibit 158: Viatris Inc. - Overview
- Exhibit 159: Viatris Inc. - Business segments
- Exhibit 160: Viatris Inc. - Key news
- Exhibit 161: Viatris Inc. - Key offerings
- Exhibit 162: Viatris Inc. - Segment focus

12.16 WellSpring Pharmaceutical Corp.
- Exhibit 163: WellSpring Pharmaceutical Corp. - Overview
- Exhibit 164: WellSpring Pharmaceutical Corp. - Product / Service
- Exhibit 165: WellSpring Pharmaceutical Corp. - Key offerings

12.17 Zydus Lifesciences Ltd.
- Exhibit 166: Zydus Lifesciences Ltd. - Overview
- Exhibit 167: Zydus Lifesciences Ltd. - Business segments
- Exhibit 168: Zydus Lifesciences Ltd. - Key offerings
- Exhibit 169: Zydus Lifesciences Ltd. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 170: Inclusions checklist
- Exhibit 171: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 172: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 173: Research methodology
- Exhibit 174: Validation techniques employed for market sizing
- Exhibit 175: Information sources

13.5 List of abbreviations
- Exhibit 176: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

motion sickness drugs market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis